176 related articles for article (PubMed ID: 8428085)
1. Soluble-type hepatobiliary contrast agents for MR imaging.
de Haën C; Gozzini L
J Magn Reson Imaging; 1993; 3(1):179-86. PubMed ID: 8428085
[No Abstract] [Full Text] [Related]
2. [Magnetic resonance tomography of the hepatobiliary system: indications, limitations and outlook].
Vogl TJ; Hammerstingl R; Schnell B; Eibl-Eibesfeldt B; Peqios W; Lissner J
Bildgebung; 1992 Dec; 59(4):195-9. PubMed ID: 1292771
[TBL] [Abstract][Full Text] [Related]
3. [Magnetic resonance imaging of the liver: what kind of contrast agents?].
De Gaspari A; De Cobelli F; Del Maschio A
Radiol Med; 2001 Sep; 102(3):109-21. PubMed ID: 11677451
[TBL] [Abstract][Full Text] [Related]
4. Hepatobiliary contrast agents for contrast-enhanced MRI of the liver: properties, clinical development and applications.
Reimer P; Schneider G; Schima W
Eur Radiol; 2004 Apr; 14(4):559-78. PubMed ID: 14986050
[TBL] [Abstract][Full Text] [Related]
5. Hepatobiliary-specific MR contrast agents: role in imaging the liver and biliary tree.
Seale MK; Catalano OA; Saini S; Hahn PF; Sahani DV
Radiographics; 2009 Oct; 29(6):1725-48. PubMed ID: 19959518
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of action of liver contrast agents: impact for clinical use.
Clément O; Siauve N; Cuénod CA; Vuillemin-Bodaghi V; Leconte I; Frija G
J Comput Assist Tomogr; 1999 Nov; 23 Suppl 1():S45-52. PubMed ID: 10608397
[TBL] [Abstract][Full Text] [Related]
7. [Status and development of new clinical contrast media for MR diagnosis of liver diseases].
Rummeny EJ; Peters PE
Radiologe; 1992 May; 32(5):225-31. PubMed ID: 1635982
[TBL] [Abstract][Full Text] [Related]
8. Enhanced tumor detection in the presence of fatty liver disease: cell-specific contrast agents.
Kreft BP; Tanimoto A; Baba Y; Zhao L; Finn JP; Stark DD
J Magn Reson Imaging; 1994; 4(3):337-42. PubMed ID: 8061431
[TBL] [Abstract][Full Text] [Related]
9. New contrast agents for imaging the liver.
Helmberger T; Semelka RC
Magn Reson Imaging Clin N Am; 2001 Nov; 9(4):745-66, vi. PubMed ID: 11694436
[TBL] [Abstract][Full Text] [Related]
10. Contrast-enhanced MR imaging of the liver.
Runge VM; Pels Rijcken TH; Davidoff A; Wells JW; Stark DD
J Magn Reson Imaging; 1994; 4(3):281-9. PubMed ID: 8061423
[TBL] [Abstract][Full Text] [Related]
11. The role of hepatocyte-specific contrast agents in hepatobiliary magnetic resonance imaging.
Burke C; Alexander Grant L; Goh V; Griffin N
Semin Ultrasound CT MR; 2013 Feb; 34(1):44-53. PubMed ID: 23395317
[TBL] [Abstract][Full Text] [Related]
12. [MR and biliary tract].
Chabanova E; Møller JM; Løgager V; Thomsen HS
Ugeskr Laeger; 2005 Aug; 167(35):3321-2; author reply 3322-3. PubMed ID: 16138986
[No Abstract] [Full Text] [Related]
13. Contrast-enhanced magnetic resonance cholangiography using mangafodipir compared with standard T2W MRC sequences: a pictorial essay.
Sheppard D; Allan L; Martin P; McLeay T; Milne W; Houston JG
J Magn Reson Imaging; 2004 Aug; 20(2):256-63. PubMed ID: 15269951
[TBL] [Abstract][Full Text] [Related]
14. Contrast agents for MR imaging of the liver.
Low RN
J Magn Reson Imaging; 1997; 7(1):56-67. PubMed ID: 9039594
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of hepatocyte-specific paramagnetic contrast media for MR imaging of hepatitis.
Tanimoto A; Kreft BP; Baba Y; Zhao L; Finn JP; Compton CC; Stark DD
J Magn Reson Imaging; 1993; 3(5):786-93. PubMed ID: 8400566
[TBL] [Abstract][Full Text] [Related]
16. Functional MR cholangiography: diagnosis of functional abnormalities of the gallbladder and biliary tree.
Fayad LM; Kamel IR; Mitchell DG; Bluemke DA
AJR Am J Roentgenol; 2005 May; 184(5):1563-71. PubMed ID: 15855116
[TBL] [Abstract][Full Text] [Related]
17. Contrast-enhanced magnetic resonance imaging of the liver with Mn-DPDP for known or suspected focal hepatic disease.
Bernardino ME; Young SW; Lee JK; Weinreb J
Invest Radiol; 1991 Nov; 26 Suppl 1():S148-9; discussion S150-5. PubMed ID: 1808113
[No Abstract] [Full Text] [Related]
18. Clinical hepatic imaging with paramagnetic positive enhancers.
Bernardino ME
Magn Reson Med; 1991 Dec; 22(2):334-8; discussion 343-6. PubMed ID: 1812367
[No Abstract] [Full Text] [Related]
19. MRI contrast media for the liver. Efficacy in conditions of acute biliary obstruction.
Leander P; Golman K; Klaveness J; Holtz E; Olsson M; Leunbach I
Invest Radiol; 1990 Oct; 25(10):1130-4. PubMed ID: 2127772
[TBL] [Abstract][Full Text] [Related]
20. Multifocal inflammatory pseudotumor of the liver: dynamic gadolinium-enhanced, ferumoxides-enhanced, and mangafodipir trisodium-enhanced MR imaging findings.
Mortelé KJ; Wiesner W; de Hemptinne B; Elewaut A; Praet M; Ros PR
Eur Radiol; 2002 Feb; 12(2):304-8. PubMed ID: 11870426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
